Zenro Nihei, MD, PhD
Articles
UFT Plus Leucovorin for Metastatic Colorectal Cancer: Japanese Experience
Wataru Ichikawa, MD, PhD;Zenro Nihei, MD, PhD;Hiroyuki Uetake, MD;Hiroyuki Yamada, MD;Yoshinori Shirota, MD;Kenichi Sugihara, MD, PhD
October 1st 2000In the United States and Europe, the combination of oral UFT plus leucovorin has been reported to produce objective responses and survival rates similar to those achieved with standard intravenous 5-fluorouracil plus leucovorin in patients with metastatic colorectal cancer, with reduced toxicity.
Latest Updated Articles
Published: September 13th 2024 | Updated: November 25th 2024
Non–clear Cell RCC: First-Line Treatment Options and Guideline Updates
Published: August 9th 2024 | Updated: August 14th 2024
Gene Assay May Predict Extended Letrozole Benefits in Breast Cancer Subsets
Published: June 2nd 2024 | Updated: June 3rd 2024
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab in Solid Tumor Indications
Published: February 13th 2015 | Updated: December 24th 2024
17-Year-Old Girl at 13 Weeks Gestation Presents With Vaginal Bleeding & Cramping
Published: December 20th 2024 | Updated: December 24th 2024
Preparing for CAR-T Therapy: Key Considerations and Timing in Multiple Myeloma Treatment
